a Department of Pediatrics and Communicable Diseases, Division of Pediatric Critical Care Medicine, and the Child Health Evaluation and Research Unit, University of Michigan, Ann Arbor, Michigan
b Department of Pediatrics, College of Medicine, University of Arkansas for Medical Sciences and Arkansas Children's Hospital, Little Rock, Arkansas
c Division of General Internal Medicine and the Child Health Evaluation and Research Unit, University of Michigan Health System, and Gerald R. Ford School of Public Policy, University of Michigan, Ann Arbor, Michigan
| ABSTRACT |
|---|
|
|
|---|
METHODS. This was a retrospective cohort study of children 0 to 17 years of age hospitalized with meningitis and requiring mechanical ventilation using the 1997 and 2000 Kids' Inpatient Database. We generated national estimates of rates of intracranial pressure monitoring and in-hospital mortality by patient and hospital characteristics, and compared in-hospital mortality, hospital length of stay, and total charges for children who received an intracranial pressure monitor with those who did not.
RESULTS. There were an estimated 1067 and 1170 hospitalizations nationally for childhood meningitis requiring mechanical ventilation in 1997 and 2000, respectively. Most (79%) of the hospitalizations involved infants. Overall, intracranial-pressure monitors were used in 7% of hospitalizations for meningitis, with the highest rates in children aged 5 to 17 years and lowest rates in children <1 year. In-hospital mortality was 19.6%, highest in children aged 5 to 17 years and in children with pneumococcal infections. In multivariate regression analyses, intracranial pressure monitor use was positively associated with age, patient volume, and hospitals located in the West census region. In-hospital mortality was associated with increasing age, hospitalization in the year 2000, self-pay/other insurance status, and pneumococcal meningitis. There was no difference in hospital mortality associated with use of intracranial pressure monitors, but both length of stay and log-transformed total hospital charges were significantly higher in the group that received an intracranial-pressure monitor.
CONCLUSION. Intracranial pressure monitoring for the treatment of critically ill children with meningitis varies by census region, the number of cases treated, and patient age. The use of intracranial pressure monitoring was not statistically associated with mortality in this national sample.
Key Words: meningitis intracranial pressure critical illness hospitalization childhood
Abbreviations: ICPintracranial pressure KIDKids' Inpatient Database ICD-9-CMInternational Classification of DiseasesNinth RevisionClinical Modification NOSnot otherwise specified CIconfidence interval ORodds ratio
Childhood meningitis is associated with significant morbidity and mortality.1,2 Intracranial pressure (ICP) is a crucial determinant of cerebral perfusion and is frequently elevated in patients with clinical meningitis, with the maximal elevation occurring within the first 24 to 48 hours after diagnosis.3,4 Elevated ICP, which causes compression of the brainstem and impairment of cerebral circulation, is an important cause of neurologic damage and mortality in patients with meningitis.57
ICP monitoring may permit physicians to target specific therapies to reduce ICP and improve brain perfusion in patients with intracranial hypertension.413 Prior studies, predominantly prospective in design, have reported reduced mortality and morbidity associated with ICP-monitor use in childhood meningitis, where the degree of intracranial hypertension is closely correlated with patient morbidity and mortality.613 Most of these studies were hampered by small sample sizes and were not intended to test the association of ICP monitoring with outcomes. The use of ICP monitors, as reported in these studies, was prompted largely by clinical findings suggestive of intracranial hypertension and not by radiologic imaging of the brain, because earlier reports had indicated poor correlation between findings on imaging of the brain and the actual presence of intracranial hypertension.6,911,14
Despite reported beneficial effects of ICP monitoring and management of intracranial hypertension in childhood meningitis, the indications for ICP-monitor use in meningitis remain unclear, and the association of the use of ICP monitors with outcome in childhood meningitis is also largely undefined. No guidelines presently exist for the use of ICP monitors in patients with meningitis, and patterns of ICP monitoring in children with meningitis are unknown. This study was conducted to describe patient and hospital characteristics associated with the use of ICP monitors and to describe outcomes in critically ill children with meningitis in the United States using a propensity scorebased matching algorithm.
| METHODS |
|---|
|
|
|---|
We generated estimates of national rates of ICP monitoring and in-hospital mortality by patient and hospital characteristics. Stepwise logistic-regression analysis was used to identify factors associated with the use of ICP monitoring and in-hospital mortality. We also used a propensity scorebased matching algorithm to compare in-hospital mortality, hospital length of stay, and total charges for children who received an ICP monitor with those who did not receive a monitor.
Sample Identification
Children with meningitis were defined using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes for a primary or secondary diagnosis of meningitis (320.0320.3, 320.7320.9, 321.0321.4, 321.8, 322.0322.2, and 322.9), including bacterial, viral, and fungal meningitis. In addition, we limited the sample to critically ill children by requiring evidence of an ICD-9-CM procedure code for mechanical ventilation using codes 93.9093.92 and 96.7096.72. We excluded patients with traumatic brain injury, because guidelines already exist for the use of ICP monitors in those patients.22 Hospitalizations with ICD-9-CM codes for ventriculoperitoneal shunts and other in-dwelling shunts were also excluded to ensure that patients within the study sample had ICP monitoring only during the index hospitalization. Pretransfer hospitalizations, for which the ultimate case disposition was unknown, were excluded, because including pretransfer hospitalizations in the analysis would overestimate the incidence of hospitalizations for meningitis and underestimate the rates of ICP-monitor use and mortality.23 ICD-9-CM procedure codes 01.18 and 02.2 were used to identify children that received an ICP monitor during the hospitalization.
We generated additional information on the etiology of meningitis using the ICD-9-CM diagnosis codes. Codes for pneumococcal, streptococcal, staphylococcal, Gram-negative, and meningitis not otherwise specified (NOS) infections were used to create separate categories. Infections with cell sizes too small for precise estimation, such as fungal, other specific bacterial, other bacterial NOS, and other bacterial diseases, were included in a final category described simply as "other etiology." Comorbidities associated with increased likelihood for the acquisition of meningitis, such as premature birth, splenic dysfunction, cancer, human immunodeficiency virus infection, and immunosuppression from organ or bone marrow transplant, were coded, but only premature birth had an adequate sample size. Finally, a derived "volume" variable was created to describe the number of cases of childhood meningitis per hospital as a measure of the patient caseload within the individual hospitals.24
The main outcomes for the study were in-hospital mortality, patient length of stay, and total hospital charges. These outcomes were assessed in relation to the use of ICP monitoring. The University of Michigan Medical School Institutional Review Board approved the study.
Statistical Analysis
The statistical analysis was aimed first at identifying factors associated with the use of ICP monitoring and in-hospital mortality and, second, to assess whether the use of ICP monitoring was statistically associated with outcomes. Using data pooled from 1997 and 2000, we calculated the number of hospitalizations and the mean rates of ICP monitoring and in-hospital mortality (with their associated 95% confidence intervals [CIs]) according to both patient and hospital characteristics. All of the estimates used the survey commands in Stata for Windows (Stata Corp, College Station, TX), which accounted for the complex survey design. Logistic-regression models for complex survey data were fit to estimate factors associated with the use of ICP monitoring and in-hospital mortality using a backward selection method. Finally, all of the variables were again tested for possible inclusion in the final model. Robust variance estimates were obtained by computing finite population corrections for random sampling without replacement of primary sampling units. Variance estimates accounted for clustering of data at the hospital level by using hospital identifiers as the primary sampling units.
To assess whether use of ICP monitoring was associated with improved outcomes, a propensity scorebased matching algorithm for nearest neighbors was created using the pscore suite of programs developed for Stata.25 Propensity analysis aims to identify patients with a similar probability of receiving ICP monitors on the basis of observed clinical characteristics and, thus, helps to adjust for the bias inherent in the decision to treat childhood meningitis with the use of ICP monitors or not.26,27 The propensity scores were created using all of the potential confounders, including age, gender, etiology, and hospital characteristics, and restricting the score to the common support area. We then generated a balanced sample of patients with an ICP monitor and patients without an ICP monitor using the propensity score to identify the nearest neighbors. This algorithm restricted the sample to patients in the common support area. The sample created from matching on nearest neighbors was then used to conduct additional analyses on the main outcome measures using multivariate regression models controlling for potential confounders, including the propensity scores. In these analyses, the independent effect of ICP monitoring on the main outcome measures was our primary interest. We used multivariate logistic regression, negative binomial regression, and multiple linear regression models to assess differences in mortality, length of hospitalization, and (log-transformed) total charges, respectively. Because of the small sample size in the matched sample, analyses conducted with the matched sample do not account for the complex survey design of the KID.
| RESULTS |
|---|
|
|
|---|
For both use of ICP monitors and in-hospital mortality, age was associated with large increases in rates (Table 1). The highest rates of ICP monitoring occurred in children aged 5 to 17 years and lowest in children <1 year of age. In-hospital mortality was highest in children aged 5 to 17 years (34.3%; 95% CI: 28.040.6%). There were some differences in the rate of ICP monitoring by etiology of meningitis with streptococcal (nonpneumococcal) infections monitored less often (3.0%; 95% CI: 1.34.7%) relative to staphylococcal infections (12.9%; 95% CI: 6.019.9%). There were also differences in mortality rates by etiology with pneumococcal infections having the highest rate of mortality (34.8%; 95% CI: 29.240.5%). The 95% CIs overlapped for other patient characteristics, such as gender, race, payer status, prematurity, and year.
|
5% and hospitals seeing
5 children having higher rates of
10%. There also were significant variations by census region, with the West having the highest rates of ICP monitoring (12.1%; 95% CI: 7.416.8%) relative to the South (4.3%; 95% CI: 2.85.8%) and the Northeast (5.2%; 95% CI: 3.96.5%). There was no evidence that greater frequency of monitoring was statistically associated with mortality.
|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
8) but not moderate or mild traumatic brain injury.22 Recent studies of critically ill patients with meningitis who received targeted treatment to reduce acute intracranial hypertension as recorded by continuous ICP-monitor use have described improved morbidity and mortality.411,13
In this report on the use of ICP monitors and outcomes in critically ill children with meningitis, we found significant variation in the use of ICP monitors by age of the patient, census region, infectious etiology, and institutional patient volume, without statistically significant differences in mortality. The observed variation by age in the use of ICP monitors for the management of meningitis; however, it runs counter to the epidemiology of meningitis in the study cohort. Whereas
80% of the study population was <1 year of age, ICP-monitor use occurred mainly among older children 5 to 17 years old. This finding could be related to the reluctance to place ICP monitors in infants because of the belief that open anterior fontanelles could act as an outlet for relief of intracranial hypertension, thereby obviating the need for ICP-monitor use. A bulging anterior fontanelle on clinical examination of an infant with meningitis is universally accepted as a sign of intracranial hypertension prompting immediate management, therefore reducing the likelihood of invasive monitoring of ICP. Infants have been reported to experience intracranial hypertension, however, and it is not known how reliable the clinical examination of the turgor of the anterior fontanelle is in predicting the likelihood of elevated ICP. There also might be increased operator level of comfort placing the monitors in older children and adolescents, compared with infants. Our finding of age variation in the use of ICP monitors with lower likelihood of use among infants corroborates findings from another recent study that described the frequency of ICP monitoring in infants and young toddlers with traumatic brain injury. The authors found that ICP was much less frequently monitored in infants (<1 year) compared with older children 1 to 2 years of age.28 The poor correlation of brain-computed tomography scans with intracranial hypertension6,911,14 and the uncommon occurrence of papilledema as a finding on clinical examination in patients with intracranial hypertension4,13 make the diagnosis of raised ICP in children with closed anterior fontanelles often difficult and may lower the threshold for ICP-monitor use in older children with meningitis.
We found differential use of ICP monitoring according to the etiology of the organism. Use of ICP monitoring was higher for pneumococcal, staphylococcal, and Gram-negative organisms compared with nonpneumococcal streptococci and meningitis NOS, despite the latter 2 etiologic categories accounting for the majority of admissions in the sample. The reasons for this finding are unknown.
The reasons for the regional variation in ICP-monitor use that we observed are also unclear. Regional practice variation has been described, often occurring without basis in clinical science or explanation by disease prevalence or illness severity.29 Our finding may reflect variation in physician practice styles originating from clinical mentorship and instruction during residency or fellowship training. The database had no information on physician characteristics (including training and expertise), physician supply, and the availability of ICP-monitoring technology, all of which could contribute to the regional variation described. Certain authors have speculated that the acute management of raised ICP in children, regardless of the etiology, varies widely because of a lack of both evidence and consensus.30 Professional controversies arising from incomplete or ambiguous scientific evidence on the value of specific services have been proposed as a reason for the variation in use rates of medical services.31 Additional study is warranted to elucidate the impact of regional variation in ICP-monitor use on health outcomes for children with meningitis. It was instructive to find that the monitors were placed more often within hospitals with higher patient volume, possibly reflecting greater experience with the placement and subsequent management of these devices.
The factors associated with mortality differed from those associated with the use of ICP monitors. Mortality was highest among children with pneumococcal meningitis, a finding that mirrors the current epidemiology of childhood meningitis.32,33 Delayed presentation for care in childhood meningitis has been associated with poor outcomes.34 It is unknown whether the higher mortality among children with self/other pay compared with other insurance types might be as a result of delayed presentation to the point of definitive care. Mortality was also highest among children hospitalized at teaching (children's and nonchildren's) hospitals where ICP monitors were also likely to be placed. This finding may reflect the admission of sicker children to these institutions. This speculation, however, warrants additional investigation.
The observed significant variation in the use of ICP monitoring was not, however, associated with lower mortality for patients in whom the monitors were used. The finding from the propensity-based analysis still may be the artifact of an observational study, and we were limited by our sample in operationalizing the propensity score method. Prior studies report greater use of invasive devices in critically ill children who eventually do not survive pediatric intensive care.35 Prospective studies, specifically, randomized clinical trials, which control for unobserved differences in the data, are often needed to ascertain a causal relationship when assessing the use of medical devices. This approach in the assessment of the use of ICP monitors for childhood meningitis is likely to be ethically challenging and not practically feasible to execute. Nonetheless, our study findings cannot be interpreted as either justifying or failing to justify the use of ICP monitors in the management of childhood meningitis on the basis of mortality benefit.
This study has other limitations. Because of the retrospective nature of the study, we could not ascertain the actual indication for ICP-monitor use in the study population. We excluded patients with head trauma or those with existing in-dwelling ventriculoperitoneal shunts, which limited the sample size but strengthened the internal and external validity of the study and reduced potential confounding of our results by these factors.
Variation in ICP-monitor use and outcomes could be explained by differences in health status, but we had limited ability to adjust for severity of illness in the study population beyond selecting for children who received mechanical ventilation. In a prior study of outcomes of a large cohort of children admitted to pediatric intensive care units for treatment of meningitis, however, the authors reported significant interinstitutional variation in the use of ICP monitors poorly correlated with coma status, a marker of illness severity.35
| CONCLUSIONS |
|---|
|
|
|---|
The relative rarity of childhood meningitis requiring mechanical ventilation may preclude the ability to conduct randomized trials to test the efficacy of ICP monitoring in this population. With recent reports of improved outcomes in childhood meningitis with ICP-monitor use, it may be possible to design prospective studies using matched cohorts with incorporation of pertinent clinical information. This study illustrates the potential for using propensity scorebased matching to test the efficacy of ICP monitoring in ongoing observational studies of childhood meningitis in centers that vary widely in their use of this device.
| FOOTNOTES |
|---|
Address correspondence to Folafoluwa O. Odetola, MD, MPH, Department of Pediatrics and Communicable Diseases, Division of Pediatric Critical Care Medicine, 6E07, 300 N Ingalls St, University of Michigan, Ann Arbor, MI 48109. E-mail: fodetola{at}med.umich.edu
This work was presented in part at the annual meeting of the Pediatric Academic Society; May 14, 2004; San Francisco, CA.
The authors have indicated they have no financial relationships relevant to this article to disclose.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. M. Robbins, T. M. Bird, J. M. Tilford, J. A. Reading, M. A. Cleves, M. E. Aitken, C. M. Druschel, and C. A. Hobbs Reduction in Newborns With Discharge Coding of In Utero Alcohol Effects in the United States, 1993 to 2002 Arch Pediatr Adolesc Med, December 1, 2006; 160(12): 1224 - 1231. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Fishman Variation in the use of intracranial-pressure monitoring and mortality in critically ill children with meningitis in the United States. Pediatrics, June 1, 2006; 117(6): 2279 - 2280. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||